NYSE:BLK
NYSE:BLKCapital Markets

BlackRock (BLK): Valuation Check as New Systematic Alternatives ETF Extends Its Liquid Alts Toolkit

BlackRock (BLK) just added another piece to its ETF toolkit with the iShares Systematic Alternatives Active ETF, extending its lead in liquid alternatives as investors hunt for smoother, less market tied return streams. See our latest analysis for BlackRock. All of this product activity, from outcome focused income ETFs to liquid alternatives like IALT, comes as BlackRock’s 1 year total shareholder return of 3.78 percent lags its powerful 3 year total shareholder return of 63.68 percent. This...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

What Arcellx (ACLX)'s Anito‑cel Phase 2 Data Means For Shareholders

Arcellx, Inc. recently reported new positive data from its pivotal Phase 2 iMMagine-1 trial of anitocabtagene autoleucel (anito-cel) in heavily pretreated relapsed or refractory multiple myeloma, highlighting deep and durable responses with a manageable safety profile and no delayed or non-ICANS neurotoxicities observed to date. With anito-cel partnered alongside Kite, a Gilead company, and holding Fast Track, Orphan Drug, and RMAT designations, Arcellx is positioning the therapy as a...
NYSE:KMX
NYSE:KMXSpecialty Retail

Is CarMax a Bargain After a 49.3% Slide Despite Recent Share Price Rebound?

If you are wondering whether CarMax is finally priced like a bargain after its brutal slide, or if it is cheap for a reason, this article is for you. The stock has bounced 5.6% over the last week and 23.9% over the past month, but it is still down 49.3% year to date and 52.6% over the last year, a classic setup that attracts value hunters and risk takers alike. Recent headlines have focused on a tougher used car demand backdrop and shifting consumer sentiment, alongside ongoing questions...
NasdaqGS:BLLN
NasdaqGS:BLLNHealthcare

BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses

BillionToOne (BLLN) has just put another big quarter on the board, with Q3 2025 revenue at about $62.8 million and Basic EPS of roughly -$0.20, as investors gauge how fast the top line can outrun still negative earnings. The company has seen revenue move from roughly $34.5 million in early 2024 to about $41.7 million later that year and then to $62.8 million in 2025, while Basic EPS shifted from about -$0.76 to -$1.30 and then to -$0.20 over the same stretch, setting up a story where rapid...
NYSE:WELL
NYSE:WELLHealth Care REITs

Is Welltower’s (WELL) Strong Same-Store NOI Hiding a Deeper Balance Sheet Advantage?

Recent updates show that Welltower Inc. reported very large normalized FFO growth and 14.5% same-store NOI growth, supported by stronger senior housing demand, occupancy gains, and active portfolio recycling through acquisitions and dispositions. A key insight is that this performance is underpinned by low leverage and ample liquidity, which give the healthcare REIT flexibility to pursue growth while managing macroeconomic and interest rate pressures. Next, we’ll examine how this strong...
NYSE:C
NYSE:CBanks

What Citigroup (C)'s Preferred Stock Reset and Funding Moves Mean for Shareholders

In early December 2025, Citigroup Inc. redeemed all US$1.50 billions of its 4.000% Series W preferred stock and simultaneously created a new 6.625% Fixed Rate Reset Noncumulative Preferred Stock, Series HH, while continuing to issue and refinance a range of senior unsecured notes across currencies and maturities. These capital and funding moves, alongside new leadership appointments in Japan and South Korea and ongoing investor outreach, suggest Citi is actively reshaping its balance sheet...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab (NasdaqGS:GRAB): Reassessing Valuation After Bullish Roadshow Update on Fintech Profitability and Growth

Grab Holdings (GRAB) just wrapped a roadshow that refocused attention on its fintech engine, with management stressing accelerated loan growth and a realistic path to segment profitability next year, alongside fresh board changes supporting execution. See our latest analysis for Grab Holdings. Despite the fintech buzz and fresh board additions, Grab’s 1 month share price return of minus 12.2 percent shows momentum has cooled, even as its 3 year total shareholder return of 56.5 percent still...
NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Berkshire Hathaway (BRK.B): Taking Stock of Valuation After a Recent Pullback in Share Price

Berkshire Hathaway (BRK.B) has quietly eased off its highs, with the stock down over the past week and month even as its year to date and 3 year returns remain comfortably positive. See our latest analysis for Berkshire Hathaway. That pullback comes after a strong run, with the latest share price at $490.43 and an 8.7% year to date share price return. The 5 year total shareholder return of 121.0% still underlines how powerful the long term compounding has been. If Berkshire’s slower momentum...
NYSE:TFX
NYSE:TFXMedical Equipment

Teleflex (TFX): Reassessing Valuation After a Quiet 16% One-Month Share Price Rebound

Teleflex (TFX) has quietly climbed about 16 % over the past month after a long stretch of weak returns, drawing fresh attention from investors who are wondering whether this rebound signals a genuine shift in sentiment. See our latest analysis for Teleflex. That 16.25% 1 month share price return stands in sharp contrast to Teleflex’s weak longer term total shareholder returns, with the 5 year total shareholder return down 66.55%. This suggests the latest move looks more like early momentum...
NYSE:ABM
NYSE:ABMCommercial Services

ABM Industries (ABM): Rethinking Valuation After Recent 1-Month Share Price Rebound

ABM Industries (ABM) has quietly outperformed the broader market over the past month, with the stock climbing about 9% even as its year to date and 1 year returns remain negative. See our latest analysis for ABM Industries. That recent 1 month share price return of 8.54% to about $45.90 stands in contrast to a weaker year to date share price return and a negative 1 year total shareholder return. This suggests near term momentum is improving even as the longer term picture remains more...
NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Should Celldex’s Global Phase 3 EMBARQ Trial for Barzolvolimab in Inducible Urticaria Require Action From CLDX Investors?

Earlier this week, Celldex Therapeutics announced it has begun a global Phase 3 EMBARQ trial of barzolvolimab in adults with cold urticaria and symptomatic dermographism who remain symptomatic despite H1 antihistamines or biologics, enrolling about 240 patients across 75 sites in 7 countries. This marks the second Phase 3 program for barzolvolimab and follows a prior placebo-controlled Phase 2 study where the drug achieved statistically significant improvements in provocation test responses...
NYSE:APO
NYSE:APODiversified Financial

Why Apollo Global Management (APO) Is Up 10.8% After $3 Billion Natural Gas Partnership Announcement

In early December 2025, Capital Power announced it had signed an MOU with Apollo Funds to pursue U.S. merchant natural gas generation acquisitions, with up to US$3.00 billion of potential equity commitments and Capital Power operating the acquired assets and earning management and performance fees. Alongside this push into large-scale energy and data-center-linked power assets, Apollo is also extending its reach in private markets through areas such as sports ownership and retirement...
NasdaqGS:AEVA
NasdaqGS:AEVAElectronic

Assessing Aeva Technologies (AEVA) Valuation After Landmark Level 3 LiDAR Supply Deal with European Automaker

Aeva Technologies (AEVA) just landed a major win, being chosen as the exclusive LiDAR supplier for a top European automaker's global Level 3 vehicle platform. This development is sparking fresh attention on the stock and its long term revenue potential. See our latest analysis for Aeva Technologies. The market has been quick to respond, with a 12.78% 7 day share price return and year to date share price gains above 200 percent signaling that sentiment and growth expectations are clearly...
NYSE:BRBR
NYSE:BRBRPersonal Products

BellRing Brands (BRBR): Valuation Check After Zacks Strong Sell Downgrade and Earnings Estimate Cut

BellRing Brands (BRBR) just landed on the Zacks Rank 5 Strong Sell list after earnings estimates were cut by about 15% over the past two months, putting fresh pressure on expectations. See our latest analysis for BellRing Brands. Even with that downgrade, the stock has bounced hard in the very short term, with a 1 month share price return of 17.79%, but that comes after a steep year to date share price decline of 55.36%. Near term momentum looks more like a sharp rebound than a decisive trend...
NYSE:NGVT
NYSE:NGVTChemicals

Has Ingevity’s 48.8% Rally in 2025 Outpaced Its Fundamental Recovery?

Wondering if Ingevity at around $58.83 is still a smart buy or if the easy money has already been made? You are not alone; this stock has quietly been drawing fresh attention from value focused investors. After a tough few years, the share price has surged, up 12.6% over the last week, 18.8% over the past month, and 48.8% year to date, even though the 3 and 5 year returns are still down 15.5% and 19.7% respectively. Part of this turnaround story reflects shifting sentiment around specialty...
NYSE:AMCR
NYSE:AMCRPackaging

Assessing Amcor (NYSE:AMCR)’s Valuation After Its Recent Share Price Decline

Amcor (AMCR) has quietly slipped about 3% over the past week and remains down roughly 12% this year, even as revenue and net income continue to grow. This sets up an interesting value debate. See our latest analysis for Amcor. At around $8.20, Amcor’s 1 year to date share price return of negative 12.3% and 1 year total shareholder return of negative 13.4% signal fading momentum, even as earnings growth nudges sentiment rather than transforms it. If you like the steady cash generation story...
NYSE:ABR
NYSE:ABRMortgage REITs

Assessing Arbor Realty Trust’s Valuation After Analyst Upgrade, Insider Buying and Q3 Dividend Hold

Analyst Upgrade Tied to Insider Buying and Q3 Dividend Hold Arbor Realty Trust (ABR) just picked up an analyst upgrade after a wave of insider buying and a mixed Q3 update that still kept its quarterly dividend steady at 0.30 dollars per share. See our latest analysis for Arbor Realty Trust. The upgrade and insider buying come against a tougher backdrop, with the share price at 9.05 dollars and a steep year to date share price return of minus 34.33 percent. At the same time, the five year...
NYSE:MMM
NYSE:MMMIndustrials

What 3M (MMM)'s Deutsche Bank Downgrade Amid Turnaround Efforts Means For Shareholders

In early December 2025, Deutsche Bank downgraded 3M from “Buy” to “Hold,” reflecting more cautious expectations for the company’s medium-term growth and aligning its outlook more closely with industrial peers. This shift in analyst sentiment comes even as 3M reports progress on its turnaround plan, including margin expansion and restructuring efforts such as the recent healthcare spin-off into Solventum. Against this backdrop of a more cautious Deutsche Bank rating, we’ll now examine how...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Is Microsoft’s Record India AI Spend and 365 Price Hike Altering The Investment Case For Microsoft (MSFT)?

Earlier this week, Microsoft said it will invest US$17.50 billion in India and more than C$7.50 billion in Canada to build out cloud and AI infrastructure, while also confirming future price increases for Microsoft 365 commercial products. By pairing record-scale data center spending in key growth markets with higher monetization of its core productivity suite, Microsoft is tightening the link between its AI expansion and the subscription revenues that fund it. We’ll now examine how this...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

How Investors Are Reacting To Equinix (EQIX) CFO Transition and New Sustainability Leadership Recognition

Equinix, Inc. recently announced that long-serving CFO Keith Taylor plans to retire in 2026 after 27 years, while the company was also named a Leader in the first IDC MarketScape: Worldwide Datacenter Services Sustainability 2025-2026 Vendor Assessment. This third‑party recognition highlights how Equinix’s early investments in renewable energy, green financing, and waste‑heat reuse are increasingly shaping its competitive positioning in datacenter services. We’ll now examine how this...
NYSE:QS
NYSE:QSAuto Components

What QuantumScape (QS)'s Eagle Line Milestone and Nasdaq Move Mean For Shareholders

QuantumScape Corporation recently completed installation of key equipment for its higher-volume QSE-5 Eagle Line solid-state battery cell production in San Jose, and plans to shift its stock listing from the New York Stock Exchange to Nasdaq on December 23, 2025 while retaining the QS ticker. Together, the Eagle Line milestone and the upcoming Nasdaq move highlight QuantumScape’s push to transition from lab-scale innovation toward more scalable, technology-focused commercialization through...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

Did Insider Selling Amid Strong Q3 Metrics Just Shift RealReal's (REAL) Investment Narrative?

In recent days, Manatuck Hill Partners cut its position in The RealReal by 350,000 shares and Chief Accounting Officer Steve Lo sold 62,355 shares, even as the value of Manatuck’s remaining stake rose to about US$13.6 million. Despite this steady pattern of insider selling, The RealReal’s latest Q3 results showed record growth in gross merchandise volume and revenue, stronger adjusted EBITDA, and higher free cash flow, supporting management’s more confident full-year outlook. We’ll now...
NYSE:WD
NYSE:WDDiversified Financial

How New Mixed-Income Deals And Survey Insights At Walker & Dunlop (WD) Have Changed Its Investment Story

In recent days, Walker & Dunlop arranged a comprehensive financing package for Newark’s 22 Fulton Street and a US$285,000,000 bridge loan for Brooklyn’s Greenpoint Central, while its annual survey at Affordable Housing Finance Live pointed to strong expectations for increased affordable housing investment. Together, these transactions and survey findings highlight Walker & Dunlop’s growing role at the intersection of multifamily development, affordable housing policy, and institutional...
NasdaqGM:FRPT
NasdaqGM:FRPTFood

Can Freshpet’s 55% Slide and Growth Plans Justify Today’s Price in 2025?

If you are wondering whether Freshpet is finally a bargain after its big slide, or if it is a value trap in disguise, this breakdown will help you assess whether the current share price makes sense. The stock has moved around lately, up about 2.7% over the last week and 15.3% over the past month, but it is still down roughly 55.8% year to date and 56.4% over the last year. This naturally raises questions about whether sentiment has swung too far. Recent headlines have focused on Freshpet's...